Vendor, Burlingame, CA
Phoenix Pharmaceuticals, Inc.
UEI P8XLC937AAK3, CAGE 3F7E4
2 awards and $0 obligated between May 21, 2024 and June 3, 2026.
Industries
NAICS on the awards, by dollars.
| Professional, Scientific, and Technical ServicesNAICS 541711 | $0 |
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $0 |
How it wins
Awards by competition, set-aside and type.
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N98024A00126May 21, 2024 | National Institutes of Health OlaoNational Institutes of Health | Biological Materials, Blood/Blood ProductsNAICS 541714, PSC 6505 | $0 |
| HHSN263201500107BMay 22, 2024 | National Institutes of Health OlaoNational Institutes of Health | Biological Materials, Blood/Blood ProductsNAICS 541711, PSC 6505 | $0 |
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 4 across 2 awards